Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heavy metal ions (e.g., zinc, copper, iron, magnesium, calcium, selenium) are present in the tumor microenvironment and influence tumor cell metabolism, immune responses, oxidative stress, and therapeutic outcomes. They act as essential components in cellular signaling, enzyme function, and structural integrity, while their dysregulation in the TME can either promote or inhibit tumor progression. Therapeutic strategies leverage metal-based nanoparticles and compounds to selectively target tumor cells or modulate the immune response within the TME.
Modulation of tumor cell metabolism, immune cell activity, and oxidative stress within the tumor microenvironment.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heavy Metal Ions in the Tumor Microenvironment (N/A).